Clinical Trials List
2007-05-30 - 2009-06-30
Phase III
Terminated3
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 郭熙文 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 葉金水 Division of Thoracic Medicine
- 溫仁和 Division of Thoracic Medicine
- 王舒儀 Division of Endocrinology
- 李建德 Division of Thoracic Medicine
- 何明霖 Division of Thoracic Medicine
- 林世鐸 Division of Endocrinology
- 陳正雄 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
225 participants